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Summary Sentence: Conditional ablation of AP-2γ results in a delay in skin development and abnormal expression of p63, K14, K1, filaggrin,
repetin and secreted Ly6/Plaur domain containing 1, key genes required for epidermal development and differentiation.
The development of the epidermis, a stratified squamous epithelium, is dependent on the regulated differentiation of keratinocytes.
Differentiation begins with the initiation of stratification, a process tightly controlled through proper gene expression. AP-2γ is expressed in skin
and previous research suggested a pathway where p63 gene induction results in increased expression of AP-2γ, which in turn is responsible for
induction of K14. This study uses a conditional gene ablation model to further explore the role of AP-2γ in skin development. Mice deficient for
AP-2γ exhibited delayed expression of p63, K14, and K1, key genes required for development and differentiation of the epidermis. In addition,
microarray analysis of E16.5 skin revealed delayed expression of additional late epidermal differentiation genes: filaggrin, repetin and secreted
Ly6/Plaur domain containing 1, in mutant mice. The genetic delay in skin development was further confirmed by a functional delay in the
formation of an epidermal barrier. These results document an important role for AP-2γ in skin development, and reveal the existence of regulatory
factors that can compensate for AP-2γ in its absence.
© 2008 Elsevier Inc. All rights reserved.Keywords: AP-2; Tcfap2c; Skin; Epidermis; Keratinocyte; Filaggrin; Keratin; Differentiation; Embryo developmentIntroduction
The mammalian AP-2 transcription factor family consists of
five members AP-2α, β, γ, δ, and ε (Eckert et al., 2005). These
transcription factors are known to regulate both proliferation
and differentiation (Hilger-Eversheim et al., 2000; Imagawa et
al., 1987; Luscher et al., 1989), are critical for embryonic
development (Auman et al., 2002; Winger et al., 2006), and are
important regulators of epidermal development and differentia-
tion (Leask et al., 1991; Byrne et al., 1994; Wang et al., 1997;
Oyama et al., 2002; Koster and Roop, 2004). Furthermore, they
display differential expression in developing and mature⁎ Corresponding author. Fax: +1 435 797 3959.
E-mail address: qwinger@cc.usu.edu (Q.A. Winger).
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doi:10.1016/j.ydbio.2008.02.017epidermis. AP-2α is only expressed in the basal layer, whereas,
AP-2γ is expressed in the basal, spinous and granular layers and
expression of AP-2β is restricted to sweat glands (Byrne et al.,
1994; Takahashi et al., 2000; Oyama et al., 2002; Panteleyev et
al., 2003). Functional AP-2 binding sites have been detected in
the promoter regions of the genes encoding the keratin
intermediate filament proteins K1, K5, K10 and K14 and the
epidermal growth factor receptor (EGFR), all of which play
critical roles in epidermal development and differentiation
(Leask et al., 1991; Byrne et al., 1994; Wang et al., 1997;
Maytin et al., 1999; Koster et al., 2006). Expression of AP-2α
represses EGFR gene transcription thereby functioning as a
checkpoint for proliferation and differentiation (Wang et al.,
2006). Mice lacking AP-2α in the epidermis have increased
expression of EGFR resulting in hyperproliferation. A combi-
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is required for the induction of gene expression critical for the
commitment of keratinocytes to stratification during embry-
ogenesis (Koster et al., 2006). This study was initiated to fur-
ther investigate the role of AP-2γ during embryonic deve-
lopment of the epidermis using a conditional AP-2γ mouse
model.
Development of the epidermis from a single layer of cells
into a fully stratified epithelium is controlled by a tightly
regulated pattern of gene expression (Koster and Roop, 2007;
Dai and Segre, 2004). The single-layered surface ectoderm
surrounding the embryo is initially characterized by the
expression of K8 and K18 (Moll et al., 1982). The expression
of K8 and K18 is lost at the time the surface ectoderm commits
to stratification and expression of K5 and K14 is induced
(Byrne et al., 1994). Commitment to stratification is dependent
on the expression of the transcription factor p63 (Koster et al.,
2004). The p63 gene produces six transcripts that contain (TA)
or lack (ΔN) a transactivation domain (Yang et al., 1999). The
TAp63α isoform has been shown to be a master molecular
switch in initiating epithelial stratification (Koster et al., 2004).
TAp63α and AP-2γ seem to be working in coordination, with
TAp63α directly inducing AP-2γ expression in the embryonic
epidermis. AP-2γ mRNA was not detected in the surface
epithelial cells in p63−/− mice (Koster et al., 2006). In turn,
increased AP-2γ levels result in the initiation of K5 and K14
gene expression (Byrne et al., 1994; Koster et al., 2006). In vitro
studies further demonstrated that in the absence of AP-2γ,
TAp63α is unable to induce the expression of K14 (Koster et
al., 2006). To further study this genetic regulatory pathway in
the embryo we created a conditional AP-2γ mutant mouse
model to investigate embryonic skin development in mice
lacking AP-2γ.
AP-2γ is necessary for development of the extraembryonic
tissues, which produce the placenta, and conventional AP-2γ
knock-out mice die around E7.5 due to defects in this tissue
(Auman et al., 2002). Therefore, in order to avoid the
embryonic lethal phenotype, the conditional ablation of AP-
2γ was produced using the Cre/loxP recombination system.
Sox2Cre mice were used to induce an epiblast specific ablation
of AP-2γ (Hayashi et al., 2002). Sox2Cre is ubiquitously
expressed in the epiblast beginning at E6.5 and produces a
complete deletion of AP-2γ in the embryo while leaving intact
AP-2γ expression in the extraembryonic tissues. Therefore, this
strategy generates a viable mouse model to explore the role of
AP-2γ in skin development.Materials and methods
Production of AP-2γ null mice
Sox2Cre mice were purchased from Jackson Labs (Bar Harbor, ME). This
strain expresses an epiblast-specific Cre recombinase gene beginning at E6.5
(Hayashi et al., 2002). Mice containing the AP-2γ null allele, have been
previously described (Auman et al., 2002). Mice with the AP-2γ floxed allele
have a conditional AP-2γ allele containing loxP sites which flank exon 6, and
allow for a gene specific deletion of AP-2γ in the presence of Cre recombinase
(Fig. 1; TW manuscript in preparation; Winger et al., 2006). The Crerecombinase will recognize the loxP sites in the AP-2γ flox allele creating an
AP-2γ allele which is missing exon 6. In order to produce offspring which
contained Sox2Cre, AP-2γ null and AP-2γ flox alleles, male mice were
generated that contained both the Sox2Cre transgene as well as the AP-2γ null
allele. These mice were mated to female mice that were homozygous for AP-2γ
flox. Embryos inheriting the AP-2γ null allele and the Sox2Cre transgene
needed only one Cre-mediated recombination event of the AP-2γ flox allele per
cell to produce a homozygous AP-2γ mutation. Littermates that did not inherit
the Sox2Cre or the AP-2γ null allele were used as controls. For timed
pregnancies, specific matings were set up in the afternoon, and the mice were
checked for vaginal plugs the following mornings. Noon of the day of the
vaginal plug was considered 0.5 days of gestation.
Genotyping of embryos was performed using PCR analysis of either
placental yolk sac samples or tail DNA. PCR reactions were carried out for 35
cycles (94 °C, 40 s; 67 °C, 40 s; 72 °C, 40 s) using Taq DNA polymerase
(Fermentas, Hanover, MD) in the supplied Taq buffer at 1× and 2 mM MgCl2.
χ2-tests were carried out using the resulting genotypes to determine if the AP-2γ
mutant embryos were found in expected Mendelian ratios at E10.5, E16.5 and
E18.5. Primers that detect the AP-2γ flox deleted allele were used to assay for
Cre mediated deletion in RNA collected from yolk sac and placental samples.
Skeletal preparations were prepared by staining with alcian blue and alizarin red
as described previously (Martin et al., 1995).
Detection of AP-2γ mRNA transcripts
Total RNAwas collected from E16.5 mouse skin using the RNeasy isolation
kit (Qiagen, Santa Clarita, CA) according to manufacturer's specifications.
cDNAwas then prepared from 1μg of total RNA and was analyzed for AP-2γ
transcripts by PCR. Primer sequences were designed to anneal in exons 6 and 7
(P1-5′-AAG CGG TGG CTG ACT ATT TAA C-3′; P2-5′-CAG GCT GAA
ATG AGA CAA ACA G-3′) of the AP-2γ gene producing a 206 bp product
from the WT and AP-2γ flox, and no amplification of the AP-2γ null or AP-2γ
flox-deleted alleles (Fig. 1). This set of primers was used to verify that AP-2γ
conditional knock-out animals were not expressing any functional AP-2γ in the
skin.
Histology and immunofluorescence
Embryos or tissues were washed in PBS and then fixed in 10% buffered
formalin overnight at 4 °C. Samples were then dehydrated, embedded and
sectioned at 5 μm and stained with H&E or used for immunofluorescence.
Primary antibodies used for immunofluorescence were guinea pig anti-K14
(Yuspa et al., 1989), rabbit anti-K1 (Yuspa et al., 1989) and mouse-anti-p63
(mAb4A4; Yang et al., 1999). Secondary antibody conjugates used were Alexa-
conjugated fluorochromes 488 goat-anti-rabbit, 594 goat anti-guinea pig and
488 goat anti-mouse (Molecular Probes). Images were acquired using a Nikon
Eclipse E600 microscope (Nikon Corporation). Objectives used were Nikon
Plan Apo 20×/0.75 and Nikon Plan Fluor 40×/1.30 Oil. Pictures were taken
using a Photometrics Coolsnap fx camera (Roper Scientific) and MetaVue
imaging software (Universal Imaging Corporation).
Affymetrix microarray analysis
Three biological replicates each of AP-2γ mutant and wild type skin RNA
were extracted from E16.5 embryos. Total RNAwas extracted using an RNeasy
kit (Qiagen) according to manufacturer's instructions, and RNAwas submitted
to the Center for Integrated Biosystems at Utah State University (Logan, UT) for
preparation of cRNA and hybridization to the GeneChip® Mouse Genome
430_2.0 Array from Affymetrix. The expression data were analyzed using tools
from the Bioconductor project (Gentleman et al., 2004). After preprocessing by
Affymetrix's PLIER correction (including quantile normalization), a nonspe-
cific filter (Chiaretti et al., 2004; Scholtens and von Heydebreck, 2005) was
used, restricting attention to probesets satisfying both of the following two
conditions: expression level above 100 on at least 20% of the arrays, and
coefficient of variability exceeding 0.3. About 42% of all probe sets satisfied the
first condition, and about 27% satisfied the second. The purpose of this filter was
to restrict attention to a more interesting set of genes (that were both expressed
Fig. 1. AP-2γmutant and conditional alleles. (A) AP-2γ flox has loxP sites flanking exon 6, AP-2γ flox deleted represents the floxed allele after the Cre recombination
event and AP-2γ null represents the allele that contains a deletion including part of exon 7. P1 and P2 show the primer locations used to verify deletion of AP-2γ flox
allele by RT-PCR. (B) Confirmation of AP-2γ flox deletion in skin of E16.5 control (+/+) and AP-2γ mutant embryos (−/−). Product size 200 bp. (C) AP-2γ mutant
embryos (−/−) are visibly smaller than control embryos (+/+) at E16.5. Weights were significantly different at E16.5 and E18.5 (mean±S.D.). Significance was
determined by Student's T-test, pb0.05a and pb0.001b. (D) Skeletal preparations show the curly tail phenotype in the mutant (−/−) but did not show other skeletal
defects compared to the control (+/+). Bar in (C)=5 mm.
189J. Guttormsen et al. / Developmental Biology 317 (2008) 187–195and exhibited some appreciable change in expression levels), and also to reduce
the severity of the multiple comparisons adjustment. The filter settings were
selected based on graphical checks of the expression data (not shown), and
reduced the number of probesets tested from 45,101 to 1414. Significant
differences in gene expression from wild type to mutant were determined based
on the moderated t-statistic of the limma/eBayes test for differential expression
(Smyth, 2004), with P-values adjusted to control the false discovery rate
(Benjamini and Hochberg, 1995) at 0.05.
Quantitative real time RT-PCR
Skin samples were taken from E16.5 and E18.5 mice. RNA was extracted
using the RNeasy isolation kit according to manufacturer's specifications
(Qiagen) and cDNA was generated using reverse transcription. Real-time RT-
PCR reactions were prepared to compare filaggrin mRNA levels using Taqman
probes (Applied Biosystems, Foster City, CA). Reactions were set up according
to manufacturer's specifications and run on a BioRad iCycler (2 min 50 °C,
10 min 95 °C, Cycle 40 times at 15 s 95 °C and 1 min 60 °C). The cycle
threshold (Ct) values were obtained from each of three replicates. Relative
expression was calculated using standard curves of 10 fold cDNA dilutions for
both filaggrin and the β-actin internal control. The relative expression of
filaggrin was normalized to endogenous β-actin expression. AP-2γ mutant
levels were calculated as a percentage of expression compared to control
samples which were determined to be 100% of expression. Results were
analyzed using Student's t-test, values of pb0.05 were considered significant.Western blots
Protein was extracted from E18.5 mouse embryonic skin using T-Per tissue
protein extraction reagent (Pierce, Rockford, IL) and samples were quantitated
on a Versa Max tunable microplate reader (Molecular Devices, Sunnyvale, CA)
using the BCA™ Protein Assay kit (Pierce) according to manufacturer's
specifications. Western blots were performed to compare filaggrin protein levels
between AP-2γ mutant and control mice. 25 μg of protein was loaded per well
for SDS-PAGE using 12% Tris–HCl Ready Gels (BioRad, Hercules, CA). The
samples were transferred to a PVDF membrane (BioRad) for blotting.
Membranes were blocked in Super Block (Pierce) for 1 h at room
temperature, the membrane was then incubated in primary antibody against
filaggrin (Provided by Dr. Roop; Waikel et al., 1999) at a dilution of 1:5000
followed by HRP-anti-rabbit secondary antibody (Rockland, Gilbertsville, PA)
and visualized using SuperSignal (Pierce) on a digital gel documentation
system (UVP). Quantification of filaggrin protein was performed by
standardization with primary antibodies against β-actin (Rockland Immuno-
chemicals, Gilbertsville, PA).
Barrier staining
Embryos were collected at E16.5, E17.5 and E18.5 and washed in PBS.
Embryos were then submerged overnight at 37 °C in X-gal (5-bromo-4-chloro-
e-indolyl-b,D-galactopyranoside) solution (100 mM NaPO4, 1.3 mM MgCl2,
3 mM K3Fe(CN)6, 3 mM K4Fe(CN)6 and 1 mg/ml X-Gal) at pH4.5. Embryos
Fig. 2. AP-2γ mutant skin shows delayed expression of proteins involved in
epidermal differentiation. Skin samples from control (A, C, E, G, I and K) and
AP-2γ mutant (B, D, F, H, J and L) embryos were sectioned and stained with
antibodies specific for epidermal development markers. p63 and K14 were
detected in control but not in mutant skin at E11.5 (A, B, E and F) but were
detected in mutant skin at E16.5. K1 was detected in control skin at E16.5 but
not in AP-2γ mutant skin (G, H, K and L). K1 expression was detected in the
AP-2γ mutant skin at E18.5. H&E staining shows a lack of stratification in
mutant samples compared to controls at both E11.5 and E16.5 (C, D, I, and J).
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assay relies on the ability of X-gal to penetrate embryonic skin prior to barrier
formation where X-gal is cleaved by endogenous β-galactosidase activity in the
skin producing a blue precipitate (Hardman et al., 1998). If the impermeable skin
barrier has already formed, the X-gal is unable to penetrate and no precipitate is
produced.
Results
Characterization of the AP-2γ mutant mice
In order to produce AP-2γmutant mice, males containing an
AP-2γ null allele and the Sox2Cre transgene were bred to
females homozygous for the AP-2γ flox allele. Offspring
inheriting the AP-2γ null allele, the AP-2γ flox allele and the
Sox2Cre transgene then underwent a single Cre recombination
event of the AP-2γ flox allele in each cell of the epiblast to
produce an AP-2γ homozygous mutant embryo (Fig. 1). After
genotyping 3-week-old offspring from 10 litters, no AP-2γ
mutant pups were found, suggesting that homozygous deletion
of AP-2γ in the epiblast beginning at E6.5 was embryonic
lethal. Embryos were collected to determine the stage of
embryonic lethality of AP-2γ mutant embryos. Genotyping
embryos obtained at E10.5, E16.5 and E18.5 showed that AP-
2γ mutant embryos were present at each developmental stage
(Table 1). Embryos collected at E10.5 showed fewer mutants
but numbers were not significantly different from expected
Mendelian ratios. At E16.5 and E18.5 AP-2γ mutant embryos
were found alive but were significantly decreased in number
compared to expected ratios (Table 1). Genotyping of newborn
litters showed that AP-2γ mutant pups were born, but these
mutants were not alive upon collection, suggesting that mutants
can survive until birth but not after.
Comparison of the Sox2Cre AP-2γmutant pups to littermate
controls revealed some phenotypic developmental differences.
The weight of AP-2γ mutant embryos was significantly less
than control littermates at E16.5 and E18.5 (Fig. 1). At E16.5
the body weight of control embryos averaged 0.71 g±0.20
(n=15), while AP-2γ mutant embryos weighed 0.35 g±0.20
(n=15). Embryos collected at E18.5 showed similar results withTable 1
Detection of AP-2γ mutant embryos at E10.5, E16.5 and E18.5
Genotype AP-2γ null/
AP-2γ flox
No Cre
AP-2γ flox-
deleted/+
Sox2Cre
AP-2γ flox/+
No Cre
AP-2γ null/
AP-2γ
flox-deleted
Sox2Cre
Exp Ob Exp Ob Exp Ob Exp Ob
E10.5 a 17 17 17 19 17 20 17 10
E16.5 b 57 67 57 64 57 75 57 22 c
E18.5 d 32 35 32 36 32 39 32 18 e
Genotypes of embryos from crosses between AP-2γ flox/flox females and
Sox2Cre and AP-2γ null heterozygous males.
“+” indicates the presence of a wild type allele.
a 66 embryos.
b 228 embryos.
c χ2 test pb0.01.
d 128 embryos.
e χ2 test pb0.01.control embryos weighing 1.4 g±0.05 (n=20) and AP-2γ
mutant embryos weighing 0.73 g±0.13 (n=20). Curly tails
were detected in 31% (10/32) of mutant embryos collected
suggesting a potential caudal neural tube closure and/or skeletal
defect; however, no other major skeletal defects were detected
in skeletal preparations (Fig. 1).
Low levels of Sox2Cre expression have been previously
detected in the yolk sac and we were able to detect the AP-2γ
mutant allele in 100% of DNA samples collected from Sox2Cre
AP-2γ mutant yolk sacs. The AP-2γ deletion in the yolk sac is
not likely to contribute to the developmental delayed phenotype
because AP-2γ is not expressed in the yolk sac (Shi and
Kellems, 1998). Sox2Cre expression has not previously been
reported in the placenta; however, PCR analysis of placental
DNA from embryos that contained the Sox2Cre and the AP-2γ
flox allele detected the presence of the AP-2γ flox deleted allele
in 56% (9/16) of the samples. Deletion of the allele was
therefore not present in all mutant embryos and was presumably
191J. Guttormsen et al. / Developmental Biology 317 (2008) 187–195restricted to the embryonic/fetal portion of the placenta. This
level of placental deletion in mutant embryos at E16.5 and
E18.5 did not result in any morphology or weight differences in
the placenta compared to littermate controls (data not shown).
Abnormal skin development in AP-2γ mutant mice
The AP-2γ mutant mice display abnormal epidermal
stratification as shown histologically by H&E staining of skin
sections at E11.5 and E16.5 (Fig. 2). The induction of skin
differentiation markers p63 at E7.5 and K14 at E9.5 indicates
keratinocyte commitment to stratification in control skin
(Koster et al., 2004; Byrne et al., 1994). Immunofluorescence
analysis on E11.5 embryos demonstrated that, unlike in control
skin, p63 and K14 protein expression was absent from the skin
of AP-2γmutant embryos (Fig. 2). However, p63 and K14 were
detected in E16.5 AP-2γ mutant skin indicating that p63 and
K14 were not entirely lost in the mutant but that the expression
was delayed.
In wild type mice, K1 expression is induced around E15.5
indicating the initiation of spinous layer formation during
keratinocyte differentiation (Bickenbach et al., 1995). As
expected, K1 protein was detected in the developing spinous
layer of control E16.5 embryos (Fig. 2). However, at this stage
AP-2γ mutant skin did not express K1, indicating that theFig. 3. Heatmap of 19 significant differentially expressed probesets. Of the 1414 prob
(4–6), 19 showed statistical significance. Colors in this heatmap correspond to expres
with lighter colors for moderate values. The dendrograms on top and at left are basespinous layer had not yet formed. We did, however, detect K1
protein in E18.5 AP-2γ mutant skin, a delay of about 3 days
compared to control skin (Fig. 2).
Differential gene expression in E16.5 control and AP-2γ
mutant skin
AP-2γ regulation of gene expression in skin development
was further investigated by microarray analysis to identify
differentially expressed genes in skin samples from mice
lacking AP-2γ. RNA was isolated from E16.5 control and AP-
2γ mutant skin and hybridized to Mouse 430_2.0 Affymetrix
chips. The data set for the microarrays has been deposited at the
National Center for Biotechnology Information Gene Expres-
sion Omnibus (GEO; www.ncbi.nlm.nih.gov/geo) as accession
number GSE10175. The expression data were analyzed using
tools available from the Bioconductor project to determine gene
expression differences. Nineteen probesets representing 18
genes were found to have statistically significant differences in
expression and are summarized in Fig. 3. Of the 18 differ-
entially expressed genes 9 were down-regulated and 9 were up-
regulated due to the AP-2γ mutation. Interestingly, AP-2γ
mutant skin showed decreased expression of late-epidermal
differentiation markers filaggrin (Flg), repetin (Rptn) and
secreted Ly6/Plaur domain containing 1 (Slurp1). In additionesets tested for differential expression from control (1–3) and AP-2γmutant skin
sion levels on a scale of dark red for lowest values to dark blue for highest values,
d on divisive analysis clustering with average linkage.
Fig. 5. AP-2γ mutant embryos have delayed skin barrier formation. Control
embryos (+/+) have established an epidermal barrier by E17.5 as shown by the
lack of blue x-gal staining. AP-2γ mutant embryos (−/−) have an incomplete
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(K12), keratin 72 (K72) and serine (or cysteine) peptidase
inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member
12 (Serpina12) were significantly decreased in the mutant skin.
All of these identified down-regulated genes, with the exception
of K12 which is cornea specific, are potentially involved in skin
development. Ten probesets representing 9 genes were
determined to be up-regulated in AP-2γmutant skin. Surfactant
associated protein D (Sftpd), lectin, galactose binding, soluble 6
(Lgals6), hydroxysteroid 11-beta dehydrogenase1 (Hsd11b1),
glutathione peroxidase 3 (Gpx3) and proline-rich acidic protein
1 (Prap1) were all determined to have increased expression in
the mutant; however, to date none of these genes have well
defined roles in the epidermis.
Analysis of filaggrin expression in AP-2γ mutant skin
To verify the differential gene expression of filaggrin,
mRNA levels were compared by real-time RT-PCR (TaqMan)Fig. 4. Quantitative real-time RT-PCR analysis on AP-2γ mutant skin. (A)
Relative filaggrin mRNA levels were significantly lower in AP-2γ mutant skin
(black bars) when compared to control skin (white bars) at E16.5, but were not
different at E18.5. Bars represent mean±S.D., significance determined by
Student t-test, apb0.05. (B) Filaggrin protein monomer levels were determined
in E18.5 AP-2γ mutant (lanes 1,2) and control (lanes 3,4) skin by Western blot.
Filaggrin levels are reduced in AP-2γ mutant skin. Bars represent mean±S.D.,
significance determined by Student t-test, apb0.05.
barrier at E17.5 as shown by the uptake of x-gal on the ventral half of the
embryo. Bar=5 mm.for AP-2γ mutant and control skin. Filaggrin is an important
factor for skin differentiation and showed the largest differential
fold change and level of significance of the down-regulated
genes. AP-2γ mutant skin samples showed an 80% decrease in
filaggrin transcript expression at E16.5 compared to control
samples (Fig. 4). The difference in expression was no longer
present at E18.5.
Expression of filaggrin protein, a late epidermal marker of
skin differentiation, is normally induced around E18.0.
Quantification of filaggrin protein by Western blot at E18.5
confirms that filaggrin protein level is lower in the mutant
compared to the control (Fig. 4).
AP-2γ mutant mice show a delay in skin barrier formation
To investigate the time of skin barrier formation, AP-2γ
mutant embryos from E16.5–E18.5 were subjected to x-gal
staining. At E16.5 both control and AP-2γ mutant embryos
stained blue indicating the barrier had not yet formed in the skin
of either genotype (Fig. 5). At E17.5, control embryos showed
complete barrier formation as indicated by the lack of any blue
staining, while AP-2γ mutant embryos absorbed stain on the
ventral side of the embryos. At E18.5, AP-2γ mutant embryos
blocked x-gal penetration indicating complete formation of the
barrier (Fig. 5).
Discussion
The commitment of keratinocytes to stratification is
dependent on the transcription factor p63 (Koster et al., 2004,
2006; Mills et al., 1999; Yang et al., 1999). A previous study
reported that in the absence of AP-2γ, TAp63α is unable to
induce K14 expression (Koster et al., 2006). The current study
investigates epidermal development in mice that are deficient
for AP-2γ. Our results show that the AP-2γmutation delays the
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including p63, K14 and K1. In wild type embryos the
developing epidermis begins to express p63 at E7.5 and K14
at E9.5, which indicates the commitment of the keratinocytes to
stratification (Byrne et al., 1994; Koster et al., 2004). However,
our data show that p63 and K14 proteins were still not detected
at E11.5 in AP-2γ mutant skin, indicating a severe delay in
expression. These proteins were both detected in mutant skin by
E16.5. We also found a similar delay for the differentiation-
specific gene K1, which is normally induced at E15.5 in the
future spinous layer of the epidermis (Bickenbach et al., 1995).
In AP-2γ mutant skin however, K1 protein was not detected at
E16.5 indicating a delay in the development of the spinous
layer. Similar to p63 and K14, K1 protein expression was not
delayed indefinitely in AP-2γ mutant mice and was detected at
E18.5 in the spinous layer.
To identify genes that are potentially regulated by AP-2γ
during skin development, we compared gene expression levels
in the mutant to control skin at E16.5. At this age, expression of
genes involved in the formation of the granular layer and the
stratum corneum is expected (Bickenbach et al., 1995; Mehrel
et al., 1990). A comparison of differential transcript expression
by microarray detected nine probesets that were down-regulated
in AP-2γ mutant skin compared to control. Three of these
probsets represent filaggrin, repetin and secreted Ly6/Plaur
domain containing 1 (Slurp1), which are all known late-
epidermal differentiation markers. Filaggrin and repetin are
both members of the “fused” gene family that are associated
with the keratin intermediate filaments and are necessary for
formation of the cornified envelope (Huber et al., 2005;
Presland et al., 2004; List et al., 2006). Slurp1 is a late
epidermal differentiation marker and is predominately
expressed in the granular layer. Mutations in the Slurp1 gene
result in Mal de Meleda (MDM) a disease characterized by
inflammatory palmoplantar keratoderma (Favre et al., 2007).
The Slurp1 gene has an AP-2 binding site just upstream of the
first exon indicating a potential for direct regulation by AP-2γ
(Mastrangeli et al., 2003). These three genes represent key
epidermal differentiation factors that are necessary for proper
formation of skin. Three additional genes, K12, K72 and
Serpina12, were found to be significantly decreased in the
mutant skin. K12 and K72 are keratin family member genes that
may be involved in skin differentiation; however, K12 has been
shown to be a corneal specific keratin and K72 to be an inner-
root-sheath-specific type II epithelial keratin in humans and
mice (Tanifuji-Terai et al., 2006; Porter et al., 2001). Serpina12
has previously been detected in the epidermis where expression
levels were increased by treatment with the corticosteroid
dexamethasone, and by the over-expression of the transcription
factor Klf4, which is a known factor required for barrier
formation (Segre et al., 1999; Patel et al., 2006).
Nine genes were identified as increased in the mutant skin
including surfactant associated protein D (Sftpd), lectin,
galactose binding, soluble 6 (Lgals6), hydroxysteroid 11-beta
dehydrogenase1 (Hsd11b1), glutathione peroxidase 3 (Gpx3)
and proline-rich acidic protein 1 (Prap1). None of these genes
have well defined roles in the epidermis. However, the role ofthese genes in inflammatory response and response to oxidative
stress might suggest that they are induced due to the abnormal
skin phenotype produced in the mutant and may not be the
direct result of the lack of AP-2γ gene regulation.
Transcripts for filaggrin, a major component of the
epidermal barrier, were dramatically down-regulated in E16.5
AP-2γ mutant skin. At E18.5, we found that transcript levels
were comparable to control; however, filaggrin protein levels
were lower in AP-2γ mutant skin than in control skin. The
developmental delay was further verified by a delay in de-
tection of the epidermal barrier. In mice, the barrier is com-
pletely formed by E17.0 (Hardman et al., 1998); however, the
barrier was incomplete in mutant embryos at E17.5 but was
complete by E18.5 even though the filaggrin protein levels were
decreased.
The microarray experiments detected relatively few differ-
entially expressed genes considering the obvious phenotype at
E16.5. At this stage, the epidermis in the mutant is essentially
one layer thick and K1 protein was not detected. However, the
microarray analysis did not detect a significant difference in K1
mRNA expression. It is possible that K1 transcripts are induced
at E16.5 in the mutant to levels similar to the control but K1
protein is not yet at detectable levels. We have shown that the
mutant embryos undergo rapid epidermal differentiation
between E16.5 when the barrier is absent to E17.5 when a
partial barrier is detected. Therefore, a second possible
explanation for not detecting more differentially expressed
genes is that the embryos used in the microarray were slightly
more advanced in their development than the mutant embryos
used for histology.
Together, our data demonstrate that Sox2Cre AP-2γ mutant
embryos have a developmental delay, one aspect of which is the
delayed initiation of epidermal morphogenesis. The absence of
p63 protein at E11.5 suggests that in the absence of AP-2γ, the
early processes necessary for epidermal initiation cannot occur
normally. One possible explanation is that AP-2γ is necessary
in the mesenchyme for the development of the dermis and for
the initial induction of p63 expression in the overlying
epidermis. During later stages of epidermal development, AP-
2γ mutant mice appear to overcome this delay and induce K14
protein. Previous research indicated that AP-2γ was necessary
for the induction of K14 (Koster et al., 2006). Our Sox2Cre
conditional model now demonstrates that without AP-2γ
expression the embryo can compensate for the absence of AP-
2γ and induce K14 expression at later developmental stages.
Redundant gene regulatory mechanisms, which may or may not
include other AP-2 family members, must compensate for the
absence of AP-2γ and allow for the initiation of skin
development. In an earlier study AP-2β expression was found
to be increased in p63−/− surface epithelial cells, which lack AP-
2γ expression (Koster et al., 2006). In AP-2γ mutant skin we
did not detect differences in the expression of the other AP-2
family members based on an examination of the microarray
data. However, functional redundancy could occur as a result of
the endogenous expression of a family member without an
induction of expression. Previous research has highlighted
redundancy between AP-2α and AP-2γ in various processes
194 J. Guttormsen et al. / Developmental Biology 317 (2008) 187–195including pre-implantation embryonic development and cranial
neural tube closure (Winger et al., 2006; Kohlbecker et al.,
2002). Therefore, the presence of AP-2α in the skin could
rescue the initiation of skin development in the AP-2γ mutants.
Mice deficient for some of the genes which displayed
delayed expression in AP-2γ mutants result in either lethal
phenotypes or skin that fails to function properly. For example,
K14 mutations have been implicated in epidermolysis bullosa
simplex and K14 null mice die a few days after birth due to
cracking and drying of the skin (Paladini and Coulombe, 1999;
El Ghalbzouri et al., 2003;) and K1 mutant mice develop
epidermolytic hyperkeratosis (Arin et al., 2000). Mutations in
p63 are implicated in ectodermal dysplasias (Rinne et al., 2007).
In addition, abnormal processing of filaggrin is observed in a
mouse model of Netherton syndrome (Hewett et al., 2005) and
mice that contain the Matriptase/MT-SP1−/− mutation are
unable to proteolytically process filaggrin resulting in death
within 48 h of birth (List et al., 2002, 2006). In humans,
mutations in the filaggrin gene cause moderate or severe
ichthyosis vulgaris (IV), the most common inherited disorder of
keratinization (Smith et al., 2006).
The Sox2Cre AP-2γ mutant mice did not display skin
abnormalities such as blistering or hyperkeratosis, and formed a
functional barrier at E18.5. Therefore, the data is inconclusive
for a role of the epidermal defect in the lethal phenotype. Mice
that contain a homozygous AP-2γ gene mutation from
conception fail to produce proper extraembryonic tissues
preventing placental development resulting in death around
E7.5 (Auman et al., 2002). The developmental delay and lethal
phenotype seen in this Sox2Cre model indicate that AP-2γ is
necessary for additional aspects of embryonic development
after E7.5. The detection of floxed gene deletion in the placenta
is a novel observation with the Sox2Cre model and should be
taken into account when using this transgene in the future.
Nevertheless, since this phenomenon was observed in only a
fraction of the mutant mice it is unlikely to be the cause of the
embryonic developmental delay seen in all mutants. In
conclusion, the Sox2Cre mediated loss of AP-2γ in the epiblast
results in developmental delay which is particularly evident in
the epidermis. At present it remains unclear whether the post-
natal lethality in this model is due to a subtle defect inherent to
the epidermis and its derivatives, or is caused by the loss of AP-
2γ in another location. Therefore, additional research is
necessary to determine the full effects of the AP-2γ mutation
during embryonic development.
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